focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Earnings, Trading Statements Calendar - Week Ahead

Fri, 08th May 2015 15:19

UK Earnings, Trading Statements Calendar 
Monday, May 11 
Finsbury Growth & Income TrustHalf Year Results 
DignityQ1 Results
DiplomaHalf Year Results 
LonminHalf Year Results 
ITE GroupHalf Year Results 
Spirax-Sarco EngineeringInterim Management Statement 
GW PharmaceuticalsHalf Year Results 
Jelf GroupHalf Year Results 
Nature GroupFull Year Results
Tuesday, May 12 
IofinaFull Year Results
HiscoxQ1 Interim Management Statement
JZ Capital PartnersFull Year Results
Vitec GroupFull Year Results
TT ElectronicsInterim Management Statement 
Just RetirementQ3 Interim Management Statement
EasyJetHalf Year Results 
ExperianFull Year Results
Verona PharmaFull Year Results
Enterprise InnsHalf Year Results 
Speedy HireFull Year Results
LXB Retail PropertiesHalf Year Results 
Spire HealthcareTrading Statement
Wednesday, May 13 
Vertu MotorsFull Year Results
Barratt DevelopmentsInterim Management Statement
International Game TechnologyQ1 Results
Compass GroupHalf Year Results 
G4SInterim Management Statement
MondiInterim Management Statement
Galliford TryInterim Management Statement
New World ResourcesQ1 Results
Partnership AssuranceQ1 Interim Management Statement 
Premier OilInterim Management Statement
CentaminQ1 Results
SABMillerFull Year Results
Thursday, May 14 
AggrekoQ1 Interim Management Statement 
Titon HoldingsHalf Year Results 
3I GroupFull Year Results
British Land CoFull Year Results
ITVInterim Management Statement
Old MutualQ1 Interim Management Statement 
EuromoneyHalf Year Results 
Rank GroupInterim Management Statement
Restaurant GroupInterim Management Statement
TalkTalk Telecom GroupFull Year Results
KellerInterim Management Statement
Centaur MediaInterim Management Statement
Marston'sHalf Year Results 
Merlin EntertainmentsInterim Management Statement
NewRiver RetailFull Year Results
SIGTrading Statement
VedantaFull Year Results
Stobart GroupFull Year Results
GraingerHalf Year Results 
Mitchells & ButlersHalf Year Results 
VesuviusInterim Management Statement
TungstenTrading Statement
Friday, May 15 
TymanInterim Management Statement
Coca-Cola HBC AGQ1 Results
Bovis HomesInterim Management Statement
  
Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
13 Jan 2020 11:08

Verona Pharma shares surge after results from latest study

(Sharecast News) - Respiratory disease-focussed biopharmaceuticals company Verona Pharma announced positive top-line data from a four week, 416 patient phase 2b dose-ranging study evaluating nebulised ensifentrine or placebo as an add-on treatment to 'Spiriva Respimat', or tiotropium, which is a long acting anti-muscarinic bronchodilator, in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).

Read more
13 Jan 2020 10:34

UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance

UK WINNERS & LOSERS SUMMARY: Spirent Up After Lifting Profit Guidance

Read more
13 Jan 2020 07:56

Verona Pharma Says Ensifentrine Study Shows Positive Results

Verona Pharma Says Ensifentrine Study Shows Positive Results

Read more
5 Nov 2019 11:29

Verona Pharma losses widen as it pours resources into ensifentrine

(Sharecast News) - Biopharmaceutical company Verona Pharma updated the market on its operations and finances for the three and nine months ended 30 September on Tuesday, highlighting positive results from the second part of its phase 2 study of the dry powder inhaler formulation of 'ensifentrine' in chronic obstructive pulmonary disorder (COPD), delivered by handheld inhaler over one week of twice-daily treatment.

Read more
5 Nov 2019 10:38

UK WINNERS & LOSERS SUMMARY: AB Foods Rises As Primark Adds US Stores

UK WINNERS & LOSERS SUMMARY: AB Foods Rises As Primark Adds US Stores

Read more
5 Nov 2019 10:15

Verona Pharma Third Quarter Loss Widens On Research & Development

Verona Pharma Third Quarter Loss Widens On Research & Development

Read more
29 Oct 2019 15:30

Inland Homes snaps up 50% stake in Cheshunt Lakeside Development

(Sharecast News) - Inland Homes on Tuesday acquired a 50% interest in joint-venture partner Cheshunt Lakeside Developments Limited that was held by CPC Group Limited.

Read more
6 Aug 2019 12:01

Verona Pharma Loss Widens In First Half On Clinical Trial Expenses

(Alliance News) - Verona Pharma PLC on Tuesday said its loss widened in the second quarter and the first half of 2019 as it progressed on clinical trials of Ensifentrine, used for the treatment of

Read more
5 Aug 2019 10:42

WINNERS & LOSERS SUMMARY: Risk-Off Trade Sends Gold Miners Higher

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 3.1%. The Mexican gold miner rose as the price of

Read more
5 Aug 2019 09:44

Verona Pharma Shares Jump 15% On Positive Ensifentrine Study Results

(Alliance News) - Verona Pharma PLC on Monday reported positive second phase test data for a dry powder inhaler formulation of its lead development product ensifentrine.The stock was 15% in

Read more
25 Jun 2019 15:31

Verona Pharma strengthens clinical team ahead of next round of trials

(Sharecast News) - Respiratory-focussed biopharmaceutical company Verona Pharma announced two senior appointments to its clinical team on Tuesday.

Read more
29 May 2019 16:23

Director dealings: Piers Morgan's spouse ups stake in Verona Pharma

(Sharecast News) - Verona Pharma revealed on Wednesday that chief financial officer Piers Morgan's wife Kayt Morgan had acquired 33,802 ordinary shares in the AIM-listed biotechnology outfit.

Read more
7 May 2019 14:41

Verona Pharma announces next study of nebulised ensifentrine

(Sharecast News) - Clinical-stage biopharmaceutical company Verona Pharma announced the initiation of a phase 2b dose-ranging study evaluating nebulised ensifentrine (RPL554) added on to a long-acting bronchodilator in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) on Tuesday.

Read more
9 Apr 2019 15:25

Verona Pharma Gets EU Patent For COPD Clinical Candidate Ensifentrine

LONDON (Alliance News) - Verona Pharma PLC on Tuesday said it secured a key patent from the European Patent Office relating to its lead development candidate, ensifentrine.The clinical that

Read more
9 Apr 2019 08:23

Verona Pharma gets another European patent on ensifentrine

(Sharecast News) - Respiratory disease-focussed clinical stage biopharmaceutical company Verona Pharma announced on Tuesday that the European Patent Office had granted an additional key patent relating to its lead development candidate, 'ensifentrine'.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.